Dental M&A 2026: Ten Shifts DSO Leaders Must Understand Now
What shift is happening in DSO acquisition strategy in 2026?
TUSK Practice Sales data shows the market has moved from growth at any cost to operational discipline. Although 69% of DSOs plan to increase acquisitions, a high-demand, low-supply environment is forcing greater deal selectivity, stricter financial scrutiny, and more realistic integration timelines.
Why are some DSOs entering lender control in 2026?
Organizations including Dental Care Alliance and Affordable Care have transitioned into lender control after debt-fueled expansion exposed them to rate pressure and integration challenges. These restructurings signal the limits of aggressive leverage and explain why lenders are now applying stricter underwriting to DSO capital requests.
What is driving the surge in dental practice PPM exits?
Private placement memorandum exits rose 57.1% as PE sponsors accelerate liquidity events. With 78% of DSOs expecting recapitalization within 12 to 36 months, sellers who can demonstrate EBITDA stability and operational maturity are attracting the strongest offers from incoming capital partners.
Dental M&A in 2026 has moved from “growth at any cost” to operational discipline, according to new data from TUSK Practice Sales. Although 69% of DSOs plan to increase acquisitions this year, a high-demand, low-supply market will make deals harder to close — TUSK expects this imbalance to persist for nine months. Several large DSOs, including Dental Care Alliance and Affordable Care, have transitioned into lender control following restructuring, signaling the limits of debt-fueled expansion. Meanwhile, private placement memorandum exits rose 57.1% last year, and 78% of DSOs anticipate recapitalization within 12–36 months. DSOs now require minimum 5-year post-close employment terms and are exiting deals over staffing and clinical continuity risks. The era of rapid network expansion is giving way to regional density, financial discipline, and technology investment.
For PE-backed operators and growth-stage DSOs, this shift demands a new acquisition playbook: tighter due diligence on provider risk, regional density over national scatter, and technology infrastructure investment before the next recapitalization cycle. Groups still chasing volume over operational maturity face the same fate as recent restructuring casualties.
While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.